Description
Product Overview: Melanotan 2 (MT-2)
Melanotan 2 (MT-2) is a synthetic, cyclic lactam analog of the peptide hormone Alpha-Melanocyte-Stimulating Hormone ($\alpha$-MSH). Engineered with enhanced enzymatic stability and receptor binding affinity, Melanotan 2 functions as a non-selective melanocortin receptor agonist—activating MC1R, MC3R, MC4R, and MC5R. It serves as a primary research compound for studying melanogenesis (skin pigmentation pathways), central appetite suppression, sexual dysfunction mechanics, and central nervous system signaling.
Primary Research Applications & Reasons for Study
- Melanogenesis & Photoprotection: Activating dermal MC1R receptors on melanocytes to stimulate eumelanin synthesis, ultraviolet (UV) radiation protection, and skin pigmentation dynamics.
- Central Appetite & Metabolic Signaling: Binding central hypothalamic MC4R receptors to study feed intake suppression, energy expenditure, and lipid homeostasis in metabolic models.
- Central Sexual Function Pathways: Investigating central nervous system activation of erectile responses and libido dynamics via central melanocortin receptor pathways independent of vascular nitric oxide pathways.
- Neuro-Inflammatory Modulation: Evaluating secondary anti-inflammatory activity through peripheral MC3R/MC5R activation in tissue injury models.
Expected Research Results & Timeline Metrics
-
Phase 1 / Hours 1–24
Acute Central Signaling & Anorectic Response: Rapid binding to central MC4R leads to immediate drops in feed intake metrics, acute elevation of melanocyte intracellular cAMP levels, and central arousal responses. -
Phase 2 / Days 3–7
Eumelanin Accumulation: Statistically significant increases in tyrosinase enzyme activity, driving dark photo-protective eumelanin synthesis in epidermal tissue cultures and rodent models. -
Phase 3 / Weeks 2–4
Sustained Pigmentation & Weight Regulation: Marked, long-lasting enhancement of baseline skin tissue pigmentation alongside sustained reductions in cumulative adipose mass and food consumption parameters.
Key Research Benefits
- High Enzymatic Stability: Cyclic lactam structure resists rapid enzymatic degradation by aminopeptidases, extending in vitro biological half-life over linear native $\alpha$-MSH.
- Broad Receptor Binding Profile: Non-selective activation across MC1R, MC3R, MC4R, and MC5R allows versatile cross-disciplinary study of skin, nervous system, and metabolic axes.
- Sunless Photoprotective Model: Triggers pigment production directly without requiring initial UV-induced DNA damage in melanocytes.
- Potent Anorectic Standard: Highly reliable positive control compound for evaluating central MC4R-mediated appetite suppression assays.
THIS PRODUCT IS INTENDED SOLELY FOR IN VITRO LABORATORY RESEARCH AND EXPERIMENTAL PURPOSES. It is strictly prohibited for human consumption, clinical trials, therapeutic administration, cosmetic use, or veterinary application. This product is not an FDA-approved drug, medical food, or dietary supplement. It is not intended to diagnose, treat, cure, or prevent any disease, illness, or medical condition. Any handling, reconstitution, or experimentation involving this chemical compound must be conducted strictly by qualified, trained laboratory professionals utilizing appropriate containment and personal protective equipment in accordance with scientific biosafety standards. Buyers and users assume full liability for compliance with local, state, and federal laws regarding the handling and possession of research compounds.